Michael E. Rome

Insider Reports History

Entity
Individual
Location
600 Montgomery Street, Suite 4500, San Francisco, CA
Signature
/s/ James P. Reilly, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael E. Rome:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kinnate Biopharma Inc. Director Stock Option (right to buy) 0 Apr 3, 2024 Direct

Insider Reports Filed by Michael E. Rome

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNTE Kinnate Biopharma Inc. Apr 3, 2024 2 $0 4 Apr 5, 2024 Director
KNTE Kinnate Biopharma Inc. Jun 13, 2022 1 $0 4 Jun 15, 2022 Director
THRX Theseus Pharmaceuticals, Inc. Oct 6, 2021 0 $0 3 Oct 6, 2021 Director